Medtronic Emphasizes International Growth Opportunities
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.
You may also be interested in...
Medtronic Signals More To Come On Its Pivot To Hospital Services
The company’s leadership team is “determined to transform Medtronic from being a primarily device provider today into the premier global medical technology solutions partner of tomorrow,” CEO Omar Ishrak said.
Boston Scientific Continues Worldwide Restructuring, Plans Job Cuts
The cuts expand on a 2011 restructuring plan, with hopes of reducing operating expenses by up to $375 million at the end of 2013.
Medtronic Ups Stake In China Cardiac Market With LifeTech Investment
The $66 million deal gives Medtronic a significant stake in LifeTech, a Chinese developer of minimally invasive devices, including balloon catheters, delivery systems, occluders and stent graft systems.